Back to search

Article

Circulating inflammatory ILC2s as a biomarker of gastric cancer progression

2026-05-01

Abstract excerpt

Gastric cancer is frequently diagnosed at an advanced stage, contributing to poor patient outcomes and highlighting the need for blood-based biomarkers that can detect disease earlier and track progression. We previously showed that a tuft cell-IL25-type 2 innate lymphoid cell (ILC2) circuit promotes gastric metaplasia and gastric tumour development, but whether this pathway gives rise to a circulating ILC2 popula...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e8208cbf-3010-537b-8995-dc3423a0d74b
DOI
10.64898/2026.04.28.721482
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating inflammatory ILC2s as a biomarker of gastric cancer progressionDOI 10.64898/2026.04.28.721482
Select a neighboring publication to make it the new centre.